Calcium-oxalate-crystal-induced bone disease

Area of Science:

• Nephrology
• Endocrinology
• Pathology

Background:

• Primary hyperoxaluria (PH) is a rare genetic disorder causing oxalate overproduction and deposition.
• Kidney transplantation is a treatment for end-stage renal disease in PH, but complications can arise.
• Bone disease is a known complication in PH patients, even post-transplantation.

Observation:

• A 13-year-old boy with PH and a functioning renal allograft presented with bone disease, hypercalcemia, and hypercalciuria.
• Bone biopsy showed calcium oxalate crystals within marrow macrophages and giant cells.
• Resorption bays were observed adjacent to these crystal-laden cells.

Findings:

• Serum 1,25-(OH)2-vitamin D (calcitriol) and intact parathyroid hormone (iPTH) levels were low or normal.
• The findings suggest a novel mechanism for hypercalcemia in PH patients with renal allografts.
• Macrophage-mediated bone resorption, induced by calcium oxalate crystal deposition, is implicated.

Implications:

• This study highlights a potential cause of hypercalcemia in PH patients post-kidney transplant.
• Understanding this mechanism may lead to targeted therapies for bone disease in PH.
• Further research is needed to elucidate the precise pathways of crystal-induced bone resorption.